Loss of TIMP3 enhances interstitial nephritis and fibrosis

Journal of the American Society of Nephrology

Volumn 20, Issue 6, 2009, Pages 1223-1235

  Kassiri, Zamaneh ^a,c   Oudit, Gavin Y ^b,c   Kandalam, Vijay ^a   Awad, Ahmed ^a   Wang, Xiuhua ^a   Ziou, Xiuhua ^d   Maeda, Nobuyo ^e   Herzenberg, Andrew M ^d   Scholey, James W ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MAZANKOWSKI ALBERTA HEART INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME DEFICIENCY; ENZYME INDUCTION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RENAL ARTERY; SIGNAL TRANSDUCTION; URETER OBSTRUCTION;

EID: 67449091409     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008050492     Document Type: Article

References (53)

1. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998 (Pubitemid 28516069)
2. Eddy AA: Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301, 2000
3. Schrier RW: Cancer therapy and renal injury. J Clin Invest 110: 743-745, 2002 (Pubitemid 35050949)
4. Moe OW: Kidney stones: Pathophysiology and medical management. Lancet 367: 333-344, 2006 (Pubitemid 43151467)
5. Nuttall RK, Sampieri CL, Pennington CJ, Gill SE, Schultz GA, Edwards DR: Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. FEBS Lett 563: 129-134, 2004 (Pubitemid 38471586)
6. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V, Docherty AJ, Murphy G: TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435: 39-44, 1998 (Pubitemid 28432011)
7. Loechel F, Fox JW, Murphy G, Albrechtsen R, Wewer UM: ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 278: 511-515, 2000
8. Kashiwagi M, Tortorella M, Nagase H, Brew K: TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAMTS5). J Biol Chem 276: 12501-12504, 2001 (Pubitemid 37385157)
9. Leco KJ, Waterhouse P, Sanchez OH, Gowing KL, Poole AR, Wakeham A, Mak TW, Khokha R: Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 108: 817-829, 2001 (Pubitemid 32884192)
10. Kassiri Z, Oudit GY, Sanchez O, Dawood F, Mohammed FF, Nuttall RK, Edwards DR, Liu PP, Backx PH, Khokha R: Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circ Res 97: 380-390, 2005 (Pubitemid 41216143)
11. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC, Khokha R: Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36: 969-977, 2004 (Pubitemid 39167493)
12. Kim H, Oda T, Lopez-Guisa J, Wing D, Edwards DR, Soloway PD, Eddy AA: TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 12: 736-748, 2001 (Pubitemid 32246702)
13. Butler DG, Zhang DH, Villadiego R, Oudit GY, Youson JH, Cadinouche MZ: Response by the corpuscles of Stannius to hypotensive stimuli in three divergent ray-finned fishes (Amia calva, Anguilla rostrata, and Catastomus commersoni): Cardiovascular and morphological changes. Gen Comp Endocrinol 132: 198-208, 2003 (Pubitemid 36694053)
14. Zhang G, Kernan KA, Collins SJ, Cai X, Lopez-Guisa JM, Degen JL, Shvil Y, Eddy AA: Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: Role of plasmin-activated signals. J Am Soc Nephrol 18: 846-859, 2007 (Pubitemid 46434501)
15. Legallicier B, Trugnan G, Murphy G, Lelongt B, Ronco P: Expression of the type IV collagenase system during mouse kidney development and tubule segmentation. J Am Soc Nephrol 12: 2358-2369, 2001 (Pubitemid 33021113)
16. Eddy AA, Kim H, Lopez-Guisa J, Oda T, Soloway PD: Interstitial fibrosis in mice with overload proteinuria: Deficiency of TIMP-1 is not protective. Kidney Int 58: 618-628, 2000 (Pubitemid 30620011)
17. Catania JM, Chen G, Parrish AR: Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 292: F905-F911, 2007 (Pubitemid 46393417)
18. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A: Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112: 1486-1494, 2003 (Pubitemid 38056275)
19. Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z: Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. J Nephrol 20: 444-452, 2007 (Pubitemid 350081499)
20. Ronco P, Lelongt B, Piedagnel R, Chatziantoniou C: Matrix metalloproteinases in kidney disease progression and repair: A case of flipping the coin. Semin Nephrol 27: 352-362, 2007 (Pubitemid 46802918)
21. Zhang G, Kim H, Cai X, Lopez-Guisa JM, Alpers CE, Liu Y, Carmeliet P, Eddy AA: Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 14: 1254-1271, 2003 (Pubitemid 36514666)
22. Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, Seiki M, Reynolds JJ, Murphy G: Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 270: 30479-30485, 1995 (Pubitemid 26005105)
23. Hauser P, Oberbauer R: Tubular apoptosis in the pathophysiology of renal disease. Wien Klin Wochenschr 114: 671-677, 2002 (Pubitemid 35033588)
24. Shastry S, Ingram AJ, Scholey JW, James LR: Homocysteine induces mesangial cell apoptosis via activation of p38-mitogen-activated protein kinase. Kidney Int 71: 304-311, 2007 (Pubitemid 46227089)
25. Baba M, Furihata M, Hong SB, Tessarollo L, Haines DC, Southon E, Patel V, Igarashi P, Alvord WG, Leighty R, Yao M, Bernardo M, Ileva L, Choyke P, Warren MB, Zbar B, Linehan WM, Schmidt LS: Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst 100: 140-154, 2008
26. Fata JE, Chaudhary V, Khokha R: Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle. Biol Reprod 65: 680-688, 2001 (Pubitemid 32777350)
27. Zheng Y, Saftig P, Hartmann D, Blobel C: Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ ADAM17). J Biol Chem 279: 42898-42906, 2004 (Pubitemid 39372180)
28. Federici M, Hribal ML, Menghini R, Kanno H, Marchetti V, Porzio O, Sunnarborg SW, Rizza S, Serino M, Cunsolo V, Lauro D, Mauriello A, Smookler DS, Sbraccia P, Sesti G, Lee DC, Khokha R, Accili D, Lauro R: Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest 115: 3494-35505, 2005 (Pubitemid 43121837)
29. Guo G, Morrissey J, McCracken R, Tolley T, Liapis H, Klahr S: Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol Renal Physiol 280: F777-F785, 2001 (Pubitemid 32441252)
30. Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, Meldrum KK: TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol 288: F406-F411, 2005 (Pubitemid 40105400)
31. Meldrum KK, Misseri R, Metcalfe P, Dinarello CA, Hile KL, Meldrum DR: TNF-alpha neutralization ameliorates obstruction-induced renal fibrosis and dysfunction. Am J Physiol Regul Integr Comp Physiol 292: R1456-R1464, 2007 (Pubitemid 46557805)
32. Lautrette A, Li S, Alili R, Sunnarborg SW, Burtin M, Lee DC, Friedlander G, Terzi F: Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach. Nat Med 11: 867-874, 2005 (Pubitemid 41161119)
33. Guo G, Morrissey J, McCracken R, Tolley T, Klahr S: Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol 277: F766-F772, 1999
34. Klahr S, Morrissey J: Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283: F861-F875, 2002 (Pubitemid 35192452)
35. Owen CA, Hu Z, Lopez-Otin C, Shapiro SD: Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metal loproteinase-resistant collagenase and serpinase. J Immunol 172: 7791-7803, 2004 (Pubitemid 38747647)
36. Nenan S, Boichot E, Lagente V, Bertrand CP: Macrophage elastase (MMP-12): A pro-inflammatory mediator? Mem Inst Oswaldo Cruz 100 [Suppl 1]: 167-172, 2005 (Pubitemid 40685458)
37. Peterson JT, Hallak H, Johnson L, Li H, O'Brien PM, Sliskovic DR, Bocan TM, Coker ML, Etoh T, Spinale FG: Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103: 2303-2309, 2001 (Pubitemid 32433722)
38. Misseri R, Rink RC, Meldrum DR, Meldrum KK: Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res 119: 149-159, 2004 (Pubitemid 38625641)
39. Henger A, Schmid H, Kretzler M: Gene expression analysis of human renal biopsies: Recent developments towards molecular diagnosis of kidney disease. Curr Opin Nephrol Hypertens 13: 313-318, 2004 (Pubitemid 38582304)
40. Nangaku M: Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern Med 43: 9-17, 2004 (Pubitemid 38208370)
41. Kawamoto H, Yasuda O, Suzuki T, Ozaki T, Yotsui T, Higuchi M, Rakugi H, Fukuo K, Ogihara T, Maeda N: Tissue inhibitor of metalloproteinase- 3 plays important roles in the kidney following unilateral ureteral obstruction. Hypertens Res 29: 285-294, 2006 (Pubitemid 43853275)
42. English JL, Kassiri Z, Koskivirta I, Atkinson SJ, Di Grappa M, Soloway PD, Nagase H, Vuorio E, Murphy G, Khokha R: Individual Timp deficiencies differentially impact pro-MMP-2 activation. J Biol Chem 281: 10337-10346, 2006 (Pubitemid 43864572)
43. Cheng S, Pollock AS, Mahimkar R, Olson JL, Lovett DH: Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 20: 1898-1900, 2006
44. Karsdal MA, Larsen L, Engsig MT, Lou H, Ferreras M, Lochter A, Delaisse JM, Foged NT: Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 277: 44061-44067, 2002 (Pubitemid 36157833)
45. George SJ, Johnson JL, Smith MA, Angelini GD, Jackson CL: Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein. J Vasc Res 42: 247-254, 2005 (Pubitemid 40981131)
46. Diamond JR, Kees-Folts D, Ding G, Frye JE, Restrepo NC: Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 266: F926-F933, 1994 (Pubitemid 2111735)
47. Diamond JR, Ricardo SD, Klahr S: Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin Nephrol 18: 594-602, 1998 (Pubitemid 28506731)
48. Ramesh G, Reeves WB: TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110: 835-842, 2002 (Pubitemid 35050961)
49. Messmer UK, Winkel G, Briner VA, Pfeilschifter J: Suppression of apoptosis by glucocorticoids in glomerular endothelial cells: Effects on proapoptotic pathways. Br J Pharmacol 129: 1673-1683, 2000 (Pubitemid 30219010)
50. Dell KM, Nemo R, Sweeney WE, Jr., Levin JI, Frost P, Avner ED: A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease. Kidney Int 60: 1240-1248, 2001 (Pubitemid 32960019)
51. Higuchi M, Yasuda O, Kawamoto H, Yotsui T, Baba Y, Ozaki T, Maeda N, Fukuo K, Rakugi H, Ogihara T: Tissue inhibitor of metalloproteinase- 3 deficiency inhibits blood pressure elevation and myocardial microvascular remodeling induced by chronic administration of Nomega- nitro-L-arginine methyl ester in mice. Hypertens Res 30: 563-571, 2007 (Pubitemid 47083127)
52. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, Khokha R, Crackower MA, Backx PH, Penninger JM, Scholey JW: Loss of angiotensin- converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 168: 1808-1820, 2006 (Pubitemid 43825302)
53. Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, Backx PH, Penninger JM, Herzenberg AM, Scholey JW: Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171: 438-451, 2007 (Pubitemid 47344677)